thiazoles has been researched along with African Lymphoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brors, B; Huber, W; Hüllein, J; Kurilov, R; Lee, KS; Lukas, M; Oleś, M; Sellner, L; Tomska, K; Wagner, L; Walther, T; Zenz, T | 1 |
| Cen, O; Dargart, JL; Fish, K; Gordon, LI; Longnecker, R | 1 |
| Rath, PC | 1 |
| Kobayashi, M; Naito, K; Nakamura, S; Ohnishi, K; Sahara, N; Shibata, K; Shigeno, K; Shinjo, K | 1 |
| Bennett, R; Dunn, SP; Feidler, KL; Gomez-Curet, I; Krueger, LJ; Perkins, RS | 1 |
| Duffy, TM; Hu, Y; Lee, FY; Li, S; Swerdlow, S; Weinmann, R | 1 |
| Johnson, TA; Press, OW | 1 |
| Buyukliev, R; Ivanov, D; Karaivanova, M; Konstantinov, S; Nikolova, A | 1 |
| Bloom, SE; Muscarella, DE | 1 |
9 other study(ies) available for thiazoles and African Lymphoma
| Article | Year |
|---|---|
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.
Topics: Acetanilides; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Burkitt Lymphoma; Cell Line, Tumor; Drug Combinations; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles | 2018 |
Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Burkitt Lymphoma; Cell Proliferation; Dasatinib; Disease Models, Animal; Gene Expression; Herpesvirus 4, Human; Mice; Mice, Transgenic; Oncogene Protein p55(v-myc); Pyrimidines; Splenomegaly; Thiazoles; Viral Matrix Proteins | 2012 |
Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.
Topics: Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Collagen Type XI; Electrophoretic Mobility Shift Assay; Humans; I-kappa B Proteins; Interferon-alpha; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53 | 2005 |
Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
Topics: Apoptosis; Base Sequence; Blotting, Western; Burkitt Lymphoma; Caspase 3; Caspases; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Primers; Etodolac; Gene Expression Regulation, Neoplastic; Humans; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Thiazines; Thiazoles | 2005 |
c-Myc inhibition negatively impacts lymphoma growth.
Topics: Animals; Burkitt Lymphoma; Down-Regulation; Fibroblasts; Gene Expression Profiling; Herpesvirus 4, Human; Oligonucleotide Array Sequence Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2006 |
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Benzamides; Blast Crisis; Burkitt Lymphoma; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles | 2006 |
Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Cells, Cultured | 2000 |
Preparation, physicochemical characterization and pharmacological study of novel ruthenium(III) complexes with imidazole and benzimidazole derivatives.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Burkitt Lymphoma; Cell Survival; Chemical Phenomena; Chemistry, Physical; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indicators and Reagents; Lethal Dose 50; Male; Mice; Ruthenium; Spectrophotometry, Infrared; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Differential activation of the c-Jun N-terminal kinase pathway in arsenite-induced apoptosis and sensitization of chemically resistant compared to susceptible B-lymphoma cell lines.
Topics: Apoptosis; Arsenites; B-Lymphocytes; Burkitt Lymphoma; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Enzyme Inhibitors; Hot Temperature; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Proteins; Thiazoles; Tumor Cells, Cultured | 2002 |